Literature DB >> 23212047

ADP-ribosylation of guanosine by SCO5461 protein secreted from Streptomyces coelicolor.

Tsuyoshi Nakano1, Yuko Matsushima-Hibiya, Masafumi Yamamoto, Azusa Takahashi-Nakaguchi, Hirokazu Fukuda, Masaya Ono, Takeji Takamura-Enya, Haruyasu Kinashi, Yukari Totsuka.   

Abstract

The Streptomyces coelicolor A3(2) genome encodes a possible secretion protein, SCO5461, that shares a 30% homology with the activity domains of two toxic ADP-ribosyltransferases, pierisins and mosquitocidal toxin. We found ADP-ribosylating activity for the SCO5461 protein product through its co-incubation with guanosine and NAD(+), which resulted in the formation of N(2)-(ADP-ribos-1-yl)-guanosine ((ar2)Guo), with a K(m) value of 110 μM. SCO5461 was further found to ADP-ribosylate deoxyguanosine, GMP, dGMP, GTP, dGTP, and cyclic GMP with k(cat) values of 150-370 s(-1). Oligo(dG), oligo(G), and yeast tRNA were also ADP-ribosylated by this protein, although with much lower k(cat) values of 0.2 s(-1) or less. SCO5461 showed maximum ADP-ribosylation activity towards guanosine at 30 °C, and maintained 20% of these maximum activity levels even at 0 °C. This is the first report of the ADP-ribosylation of guanosine and guanine mononucleotides among the family members of various ADP-ribosylating enzymes. We additionally observed secretion of the putative gene product, SCO5461, in liquid cultures of S. coelicolor. We thus designated the SCO5461 protein product as S. coelicolor ADP-ribosylating protein, ScARP. Our current results could offer new insights into not only the ADP-ribosylation of small molecules but also signal transduction events via enzymatic nucleoside modification by toxin-related enzymes.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23212047     DOI: 10.1016/j.toxicon.2012.11.019

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  8 in total

1.  Substrate N2 atom recognition mechanism in pierisin family DNA-targeting, guanine-specific ADP-ribosyltransferase ScARP.

Authors:  Toru Yoshida; Hideaki Tsuge
Journal:  J Biol Chem       Date:  2018-08-02       Impact factor: 5.157

2.  Disruption of Macrodomain Protein SCO6735 Increases Antibiotic Production in Streptomyces coelicolor.

Authors:  Jasna Lalić; Melanija Posavec Marjanović; Luca Palazzo; Dragutin Perina; Igor Sabljić; Roko Žaja; Thomas Colby; Bruna Pleše; Mirna Halasz; Gytis Jankevicius; Giselda Bucca; Marijan Ahel; Ivan Matić; Helena Ćetković; Marija Luić; Andreja Mikoč; Ivan Ahel
Journal:  J Biol Chem       Date:  2016-09-15       Impact factor: 5.157

Review 3.  Targeting ADP-ribosylation as an antimicrobial strategy.

Authors:  Giuliana Catara; Annunziata Corteggio; Carmen Valente; Giovanna Grimaldi; Luca Palazzo
Journal:  Biochem Pharmacol       Date:  2019-06-06       Impact factor: 5.858

Review 4.  (ADP-ribosyl)hydrolases: structure, function, and biology.

Authors:  Johannes Gregor Matthias Rack; Luca Palazzo; Ivan Ahel
Journal:  Genes Dev       Date:  2020-02-06       Impact factor: 11.361

Review 5.  Common Mechanism for Target Specificity of Protein- and DNA-Targeting ADP-Ribosyltransferases.

Authors:  Toru Yoshida; Hideaki Tsuge
Journal:  Toxins (Basel)       Date:  2021-01-07       Impact factor: 4.546

6.  Mapping the DNA-Binding Motif of Scabin Toxin, a Guanine Modifying Enzyme from Streptomyces scabies.

Authors:  Maritza Vatta; Bronwyn Lyons; Kayla A Heney; Taylor Lidster; A Rod Merrill
Journal:  Toxins (Basel)       Date:  2021-01-13       Impact factor: 4.546

7.  Streptomyces coelicolor macrodomain hydrolase SCO6735 cleaves thymidine-linked ADP-ribosylation of DNA.

Authors:  Andrea Hloušek-Kasun; Petra Mikolčević; Johannes Gregor Matthias Rack; Callum Tromans-Coia; Marion Schuller; Gytis Jankevicius; Marija Matković; Branimir Bertoša; Ivan Ahel; Andreja Mikoč
Journal:  Comput Struct Biotechnol J       Date:  2022-08-08       Impact factor: 6.155

Review 8.  ADP-ribosylation: new facets of an ancient modification.

Authors:  Luca Palazzo; Andreja Mikoč; Ivan Ahel
Journal:  FEBS J       Date:  2017-04-26       Impact factor: 5.542

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.